RJA
BME icon

Raymond James & Associates’s BlackRock Health Sciences Trust BME Stock Holding History

Raymond James & Associates’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.91M Buy
45,502
+625
+1% +$25.9K ﹤0.01% 2254
2024
Q2 		$1.83M Buy
44,877
+2,931
+7% +$117K ﹤0.01% 2218
2024
Q1 		$1.74M Buy
41,946
+1,273
+3% +$53.3K ﹤0.01% 2254
2023
Q4 		$1.65M Buy
40,673
+1,375
+3% +$52.5K ﹤0.01% 2216
2023
Q3 		$1.54M Buy
39,298
+687
+2% +$27.4K ﹤0.01% 2177
2023
Q2 		$1.57M Buy
38,611
+955
+3% +$39.3K ﹤0.01% 2206
2023
Q1 		$1.58M Buy
37,656
+778
+2% +$32.7K ﹤0.01% 2183
2022
Q4 		$1.61M Buy
36,878
+229
+0.6% +$9.73K ﹤0.01% 2136
2022
Q3 		$1.42M Buy
36,649
+177
+0.5% +$7.54K ﹤0.01% 2177
2022
Q2 		$1.55M Sell
36,472
-68
-0.2% -$2.95K ﹤0.01% 2174
2022
Q1 		$1.66M Buy
36,540
+1,207
+3% +$53.5K ﹤0.01% 2253
2021
Q4 		$1.71M Buy
35,333
+8,942
+34% +$423K ﹤0.01% 2278
2021
Q3 		$1.26M Buy
26,391
+825
+3% +$40.2K ﹤0.01% 2422
2021
Q2 		$1.24M Buy
25,566
+3,559
+16% +$170K ﹤0.01% 2441
2021
Q1 		$1.02M Buy
22,007
+4,808
+28% +$228K ﹤0.01% 2501
2020
Q4 		$818K Sell
17,199
-449
-3% -$20.4K ﹤0.01% 2470
2020
Q3 		$756K Buy
17,648
+286
+2% +$12.2K ﹤0.01% 2348
2020
Q2 		$708K Sell
17,362
-3,930
-18% -$159K ﹤0.01% 2369
2020
Q1 		$768K Buy
21,292
+1,188
+6% +$47.3K ﹤0.01% 2143
2019
Q4 		$854K Buy
20,104
+1,177
+6% +$46.7K ﹤0.01% 2368
2019
Q3 		$724K Buy
18,927
+704
+4% +$27.1K ﹤0.01% 2392
2019
Q2 		$709K Sell
18,223
-1,425
-7% -$54.2K ﹤0.01% 2423
2019
Q1 		$782K Sell
19,648
-3,478
-15% -$137K ﹤0.01% 2348
2018
Q4 		$843K Buy
23,126
+271
+1% +$10.7K ﹤0.01% 2183
2018
Q3 		$972K Buy
22,855
+9,033
+65% +$366K ﹤0.01% 2278
2018
Q2 		$533K Buy
13,822
+300
+2% +$10.9K ﹤0.01% 2634
2018
Q1 		$473K Sell
13,522
-650
-5% -$23.1K ﹤0.01% 2604
2017
Q4 		$517K Hold
14,172
– – ﹤0.01% 2514
2017
Q3 		$517K Buy
14,172
+753
+6% +$27.4K ﹤0.01% 2465
2017
Q2 		$492K Buy
13,419
+1,586
+13% +$55.6K ﹤0.01% 2432
2017
Q1 		$409K Buy
11,833
+270
+2% +$9.08K ﹤0.01% 2512
2016
Q4 		$367K Buy
11,563
+3,016
+35% +$101K ﹤0.01% 2517
2016
Q3 		$294K Buy
8,547
+730
+9% +$25.8K ﹤0.01% 2636
2016
Q2 		$278K Buy
7,817
+500
+7% +$18.3K ﹤0.01% 2453
2016
Q1 		$259K Buy
+7,317
New +$258K ﹤0.01% 2427
2015
Q3 		– Sell
-10,417
Closed -$446K – 2273
2015
Q2 		$446K Buy
+10,417
New +$447K ﹤0.01% 2134

Other funds holding BME

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CA
Cornerstone Advisory Hunt Valley, Maryland $1.21B AUM 19.13% 1-Year Est. Return

Raymond James & Associates's BME Position: Q3 2024 in Review

Raymond James & Associates increased its BlackRock Health Sciences Trust (BME) stake by 1.4% in Q3 2024, buying an estimated $25.9K and bringing the position to 45,502 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2254.

Raymond James & Associates first reported a position in BME in Q2 2015 and has held it in 36 quarters since. 73 funds tracked by Wall St. Rank hold BME as of Q3 2024.

  • Raymond James & Associates held 45,502 shares of BlackRock Health Sciences Trust worth $1.91M as of Q3 2024.
  • Raymond James & Associates bought 625 BlackRock Health Sciences Trust shares in Q3 2024, an estimated $25.9K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2254 holding.
  • Raymond James & Associates first reported a position in BlackRock Health Sciences Trust in Q2 2015 and has held it in 36 quarters since.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.